MarketInOut Stock Screener Log In | Sign Up

Aptamer Group Plc

LSE • Healthcare • Biotechnology • Quote as of 10/30/2026
Aptamer Group Plc stock price and volume chart

Company Profile

IndustryBiotechnology
SectorHealthcare
ExchangeLSE
Market Capitalization10.92 mln
Float2,841 mln
Earnings Date04/01/2027

Piotroski F-Score

5 / 9
Neutral

Beneish M-Score

-1.15
Manipulation likely

Relative Strength

19 / 100
Significantly lagging

Debt / Equity

0.03
Debt-free

Pre-Tax Margin

-181%
Severely loss-making

ROE

-59.60
Deeply negative

Business Description

Founded in 2008 and based in York, UK, Aptamer Group develops and supplies specialized molecules called aptamers that can be designed to attach to specific biological targets. These molecules serve a wide range of industries, from drug development and medical testing to cosmetics and consumer health products. The company works with major organizations including AstraZeneca, Unilever, and several academic institutions, selling its solutions to clients across Europe, the United States, and beyond.

Key Fundamentals

EPS-0.10
ROE-59.60
RPS0.00
ROIC-118
ROA-40.64
Interest Cover-86.42
EBITDA, mln-2.51
EV / EBITDA-2.83
EV / EBIT-2.57
Revenue, mln1.54
EV / Revenue4.59

Quote Details

Last 0.3045
Change -0.0023 (-0.75%)
Open 0.3068
Volume 515,781
Turnover 157,055
Average Volume 5,282,285

Financial Ratios

Pre-Tax Profit Margin-181
Leverage Ratio1.25
Current Ratio4.40
Price / Book1.63
Debt / Equity0.03
Price / Sales3.25

Financial Strength

Altman Z-Score1.18
Piotroski F-Score 5 / 9
Beneish M-Score-1.15

Price Performance & Relative Strength

Period Price Performance Relative Strength
1 Week -0.52% 38 / 100   
1 Month -3.03% 34 / 100   
2 Months -37.02% 3 / 100   
6 Months -44.64% 3 / 100   
1 Year -63.96% 3 / 100   



Disclaimer - Privacy Policy - Terms of Service - Cookies - FAQ - Affiliates - Blog